Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies
PHILADELPHIA -- (Nov. 13, 2018) -- Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that...












